Aethlon Medical, Inc. AEMD
5.75 USD -0.05 (-0.86%)
At closeNov 4, 2026, 7:12 PM EST
5.61 -0.14 -2.43%
After hours · Nov 4, 7:12 PM ET
5.60 Day range 5.85
1.41 52-week range 25.65
- YTD
- -58.48%
- 1 year
- -74.56%
- Market cap
- 9.22M
- EPS (ttm)
- -32.97
- Shares out
- 13.96M
- Forward P/E
- -0.86
- YTD return
- -58.48%
- 1-year return
- -74.56%
- Volume
- 15.80K
- Avg volume
- 2.57M
- Open
- 5.68
- Previous close
- 5.80
- Day's range
- 5.60 – 5.85
- 52-week range
- 1.41 – 25.65
- Beta
- 1.75
- Price target
- 3.85 (-33.0%)
- Earnings date
- Feb 12, 2025
5D +0.17 (+3.11%)
Key statistics
- Enterprise value
- -2.65M
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.26
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- 0.00%
- Free cash flow
- -5.21M
- Total cash
- 9.07M
- Total debt
- 869.95K
- Return on equity
- -105.38%
- Short % of float
- 2.07%
- 50-day average
- 0.4028
- 200-day average
- 0.6753
Analyst view
Price target (mean) 3.85 -33.0% downside
Now 5.75
- Target (low)
- 0.70
- Target (mean)
- 3.85
- Target (high)
- 7.00
Ratings (0m) 2 1 buy · 1 hold · 0 sell
- Strong buy1
- Buy0
- Hold1
- Sell0
- Strong sell0
Next earnings
Feb 12, 2025
Expected Feb 12, 2025. Consensus EPS estimate -0.20333.
Financials — quick view
AEMD Revenue — quarterly 0
AEMD Net income — quarterly -1.55M
AEMD EPS — quarterly -4.02
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Feb 12, 2025 | Dec 1, 2024 | -0.22 | — | — | — |
| Nov 13, 2024 | Sep 1, 2024 | -0.20 | -0.20 | 0.00 | 0.00% |
| Aug 14, 2024 | Jun 1, 2024 | -0.44 | -0.34 | +0.10 | +22.73% |
| Jun 27, 2024 | Mar 1, 2024 | -1.18 | -0.91 | +0.27 | +22.88% |
| Feb 14, 2024 | Dec 1, 2023 | -1.23 | -1.37 | -0.14 | -11.38% |
| Nov 14, 2023 | Sep 1, 2023 | -1.35 | -1.22 | +0.13 | +9.63% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 15, 2024 | HC Wainwright & Co. | reit | Buy | Buy |
| Jun 24, 2024 | HC Wainwright & Co. | main | Buy | Buy |
| Mar 4, 2024 | HC Wainwright & Co. | main | Buy | Buy |
| Oct 24, 2023 | HC Wainwright & Co. | main | Buy | Buy |
About Aethlon Medical, Inc.
Aethlon Medical, Inc., a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device for cancer and life-threatening viral infections and use in organ transplantation. The company was founded in 1984 and is based in San Diego, California.
- Sector
- Healthcare
- Industry
- Medical Devices
- Country
- United States
- Website
- aethlonmedical.com
News
12 Health Care Stocks Moving In Tuesday's Pre-Market Session 
Aethlon Medical, Inc. (AEMD) Shareholder/Analyst Call Prepared Remarks Transcript 
SHAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Aethlon Medical, Inc. (NASDAQ: AEMD) 
SHAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Aethlon Medical, Inc. (NASDAQ: AEMD) 
Aethlon Stock Pulls Back: What's Going On? 
Aethlon Stock Pulls Back: What's Going On? 
12 Health Care Stocks Moving In Friday's Pre-Market Session - Aethlon Medical Q1 2027 Earnings Call Transcript
Aethlon Medical, Oklo, CID HoldCo, Xenon Pharmaceuticals and Moderna: Why These 5 Stocks Are on Investors' Radars Today 
Crude Oil Down 1%; US Pending Home Sales Rise 0.3% In August
Your note
Sign in to keep a note on AEMD — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BROENNIMAN EDWARD G | Director | Stock Award(Grant) | Apr 15, 2024 | 45,464 |
| GIKAKIS NICOLAS | Director | Stock Award(Grant) | Apr 15, 2024 | 46,574 |
| ROSSETTI ANGELA | Director | Stock Award(Grant) | Apr 15, 2024 | 200,543 |
| SHAH CHETAN S | Director | Stock Award(Grant) | Apr 15, 2024 | 44,532 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| UBS Group AG | 1.56% | 218,253 | 124.30K | Sep 29, 2024 |
| Geode Capital Management, LLC | 0.70% | 98,394 | 56.03K | Sep 29, 2024 |
| Vanguard Group Inc | 0.15% | 21,230 | 12.09K | Sep 29, 2024 |
| Baader Bank Aktiengesellschaft | 0.12% | 17,329 | 9.87K | Sep 29, 2024 |
| Two Sigma Investments, LP | 0.11% | 15,436 | 8.79K | Sep 29, 2024 |
| Two Sigma Securities, LLC | 0.10% | 13,738 | 7.82K | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Fidelity Extended Market Index Fund | 0.53% | 73,859 | 42.06K | Oct 30, 2024 |
| Vanguard Extended Market Index Fund | 0.15% | 21,224 | 12.09K | Sep 29, 2024 |
| Fidelity Series Total Market Index Fund | 0.12% | 17,412 | 9.92K | Oct 30, 2024 |
| Fidelity Total Market Index Fund | 0.02% | 2,534 | 1.44K | Oct 30, 2024 |